nodes	percent_of_prediction	percent_of_DWPC	metapath
Tamoxifen—SULT1A1—coronary artery disease	0.218	0.628	CbGaD
Tamoxifen—ESR2—coronary artery disease	0.0613	0.177	CbGaD
Tamoxifen—ESR1—coronary artery disease	0.0378	0.109	CbGaD
Tamoxifen—CES1—Trandolapril—coronary artery disease	0.0344	0.0808	CbGbCtD
Tamoxifen—CES1—Clopidogrel—coronary artery disease	0.0315	0.0739	CbGbCtD
Tamoxifen—CYP2C19—coronary artery disease	0.0303	0.0873	CbGaD
Tamoxifen—ABCB11—Rosuvastatin—coronary artery disease	0.0116	0.0273	CbGbCtD
Tamoxifen—ABCB11—Pravastatin—coronary artery disease	0.0106	0.0249	CbGbCtD
Tamoxifen—ABCC2—Olmesartan—coronary artery disease	0.0104	0.0244	CbGbCtD
Tamoxifen—ABCC2—Pitavastatin—coronary artery disease	0.00831	0.0195	CbGbCtD
Tamoxifen—ABCC2—Telmisartan—coronary artery disease	0.00831	0.0195	CbGbCtD
Tamoxifen—ABCG2—Pitavastatin—coronary artery disease	0.00751	0.0176	CbGbCtD
Tamoxifen—ABCG2—Telmisartan—coronary artery disease	0.00751	0.0176	CbGbCtD
Tamoxifen—CYP2C8—Fenofibrate—coronary artery disease	0.0066	0.0155	CbGbCtD
Tamoxifen—ABCC2—Ezetimibe—coronary artery disease	0.00613	0.0144	CbGbCtD
Tamoxifen—CYP2B6—Clopidogrel—coronary artery disease	0.00604	0.0142	CbGbCtD
Tamoxifen—CYP3A7—Eplerenone—coronary artery disease	0.0059	0.0138	CbGbCtD
Tamoxifen—CYP3A7-CYP3A51P—Eplerenone—coronary artery disease	0.0059	0.0138	CbGbCtD
Tamoxifen—ABCC2—Simvastatin—coronary artery disease	0.00569	0.0134	CbGbCtD
Tamoxifen—ABCC2—Pravastatin—coronary artery disease	0.00557	0.0131	CbGbCtD
Tamoxifen—ABCC2—Lovastatin—coronary artery disease	0.00557	0.0131	CbGbCtD
Tamoxifen—ABCG2—Ezetimibe—coronary artery disease	0.00554	0.013	CbGbCtD
Tamoxifen—ABCG2—Rosuvastatin—coronary artery disease	0.00554	0.013	CbGbCtD
Tamoxifen—CYP2C8—Gemfibrozil—coronary artery disease	0.00528	0.0124	CbGbCtD
Tamoxifen—ABCC2—Atorvastatin—coronary artery disease	0.00508	0.0119	CbGbCtD
Tamoxifen—ABCG2—Pravastatin—coronary artery disease	0.00504	0.0118	CbGbCtD
Tamoxifen—ABCB1—Ticagrelor—coronary artery disease	0.00502	0.0118	CbGbCtD
Tamoxifen—CYP3A5—Clopidogrel—coronary artery disease	0.00476	0.0112	CbGbCtD
Tamoxifen—ABCC2—Furosemide—coronary artery disease	0.00474	0.0111	CbGbCtD
Tamoxifen—CYP2C9—Fenofibrate—coronary artery disease	0.00461	0.0108	CbGbCtD
Tamoxifen—CYP2C8—Clopidogrel—coronary artery disease	0.00458	0.0107	CbGbCtD
Tamoxifen—CYP2C19—Gemfibrozil—coronary artery disease	0.00443	0.0104	CbGbCtD
Tamoxifen—CYP3A5—Eplerenone—coronary artery disease	0.00443	0.0104	CbGbCtD
Tamoxifen—CYP1A2—Gemfibrozil—coronary artery disease	0.00409	0.00959	CbGbCtD
Tamoxifen—CYP2C8—Pitavastatin—coronary artery disease	0.004	0.00939	CbGbCtD
Tamoxifen—CYP2C19—Clopidogrel—coronary artery disease	0.00384	0.00901	CbGbCtD
Tamoxifen—CYP3A7—Simvastatin—coronary artery disease	0.0038	0.00892	CbGbCtD
Tamoxifen—CYP3A7-CYP3A51P—Simvastatin—coronary artery disease	0.0038	0.00892	CbGbCtD
Tamoxifen—CYP3A7-CYP3A51P—Lovastatin—coronary artery disease	0.00372	0.00873	CbGbCtD
Tamoxifen—CYP3A7—Lovastatin—coronary artery disease	0.00372	0.00873	CbGbCtD
Tamoxifen—CYP2C9—Gemfibrozil—coronary artery disease	0.00368	0.00864	CbGbCtD
Tamoxifen—CYP2B6—Simvastatin—coronary artery disease	0.00362	0.0085	CbGbCtD
Tamoxifen—CYP1A2—Clopidogrel—coronary artery disease	0.00354	0.00832	CbGbCtD
Tamoxifen—CYP3A7-CYP3A51P—Atorvastatin—coronary artery disease	0.00339	0.00795	CbGbCtD
Tamoxifen—CYP3A7—Atorvastatin—coronary artery disease	0.00339	0.00795	CbGbCtD
Tamoxifen—CYP2C19—Telmisartan—coronary artery disease	0.00336	0.00788	CbGbCtD
Tamoxifen—CYP2B6—Atorvastatin—coronary artery disease	0.00323	0.00757	CbGbCtD
Tamoxifen—CYP2C9—Clopidogrel—coronary artery disease	0.00319	0.00749	CbGbCtD
Tamoxifen—ABCB1—Clopidogrel—coronary artery disease	0.0031	0.00727	CbGbCtD
Tamoxifen—ABCB1—Perindopril—coronary artery disease	0.0031	0.00727	CbGbCtD
Tamoxifen—CYP3A5—Rosuvastatin—coronary artery disease	0.00307	0.0072	CbGbCtD
Tamoxifen—CYP3A4—Ticagrelor—coronary artery disease	0.00301	0.00705	CbGbCtD
Tamoxifen—CYP2C8—Acetylsalicylic acid—coronary artery disease	0.00287	0.00675	CbGbCtD
Tamoxifen—CYP3A5—Simvastatin—coronary artery disease	0.00285	0.00669	CbGbCtD
Tamoxifen—CYP3A5—Pravastatin—coronary artery disease	0.00279	0.00655	CbGbCtD
Tamoxifen—CYP3A5—Lovastatin—coronary artery disease	0.00279	0.00655	CbGbCtD
Tamoxifen—CYP2C9—Pitavastatin—coronary artery disease	0.00279	0.00655	CbGbCtD
Tamoxifen—CYP2C8—Simvastatin—coronary artery disease	0.00274	0.00644	CbGbCtD
Tamoxifen—CYP2C9—Valsartan—coronary artery disease	0.00272	0.00637	CbGbCtD
Tamoxifen—ABCB1—Telmisartan—coronary artery disease	0.00271	0.00636	CbGbCtD
Tamoxifen—ABCB1—Pitavastatin—coronary artery disease	0.00271	0.00636	CbGbCtD
Tamoxifen—CYP2C19—Timolol—coronary artery disease	0.00271	0.00635	CbGbCtD
Tamoxifen—CYP2C8—Lovastatin—coronary artery disease	0.00268	0.0063	CbGbCtD
Tamoxifen—CYP2C8—Pravastatin—coronary artery disease	0.00268	0.0063	CbGbCtD
Tamoxifen—CYP3A4—Fenofibrate—coronary artery disease	0.00268	0.00629	CbGbCtD
Tamoxifen—ABCB1—Lisinopril—coronary artery disease	0.00257	0.00603	CbGbCtD
Tamoxifen—ABCB1—Enalapril—coronary artery disease	0.00257	0.00603	CbGbCtD
Tamoxifen—CYP3A5—Atorvastatin—coronary artery disease	0.00254	0.00597	CbGbCtD
Tamoxifen—CYP2C19—Rosuvastatin—coronary artery disease	0.00247	0.00581	CbGbCtD
Tamoxifen—CYP2C8—Atorvastatin—coronary artery disease	0.00244	0.00574	CbGbCtD
Tamoxifen—CYP2C9—cardial valve—coronary artery disease	0.00244	0.153	CbGeAlD
Tamoxifen—CYP2C19—Acetylsalicylic acid—coronary artery disease	0.00241	0.00566	CbGbCtD
Tamoxifen—CYP3A5—Losartan—coronary artery disease	0.00233	0.00546	CbGbCtD
Tamoxifen—CYP2C19—Simvastatin—coronary artery disease	0.0023	0.0054	CbGbCtD
Tamoxifen—CYP2C19—Lovastatin—coronary artery disease	0.00225	0.00528	CbGbCtD
Tamoxifen—CYP2C8—Losartan—coronary artery disease	0.00224	0.00525	CbGbCtD
Tamoxifen—CYP2D6—Niacin—coronary artery disease	0.00221	0.00519	CbGbCtD
Tamoxifen—ABCB1—Timolol—coronary artery disease	0.00218	0.00512	CbGbCtD
Tamoxifen—CYP3A4—Gemfibrozil—coronary artery disease	0.00214	0.00502	CbGbCtD
Tamoxifen—CYP2C9—Rosuvastatin—coronary artery disease	0.00206	0.00483	CbGbCtD
Tamoxifen—CYP2D6—Timolol—coronary artery disease	0.00206	0.00483	CbGbCtD
Tamoxifen—CYP2C19—Atorvastatin—coronary artery disease	0.00205	0.00481	CbGbCtD
Tamoxifen—CYP2C9—Acetylsalicylic acid—coronary artery disease	0.00201	0.00471	CbGbCtD
Tamoxifen—ABCB1—Ezetimibe—coronary artery disease	0.002	0.00469	CbGbCtD
Tamoxifen—ABCB1—Acetylsalicylic acid—coronary artery disease	0.00195	0.00457	CbGbCtD
Tamoxifen—ABCB1—Captopril—coronary artery disease	0.00192	0.00451	CbGbCtD
Tamoxifen—CYP2C9—Simvastatin—coronary artery disease	0.00191	0.00449	CbGbCtD
Tamoxifen—CYP2C19—Losartan—coronary artery disease	0.00188	0.0044	CbGbCtD
Tamoxifen—CYP2C9—Lovastatin—coronary artery disease	0.00187	0.00439	CbGbCtD
Tamoxifen—CYP2C9—Pravastatin—coronary artery disease	0.00187	0.00439	CbGbCtD
Tamoxifen—CYP3A4—Clopidogrel—coronary artery disease	0.00186	0.00436	CbGbCtD
Tamoxifen—ABCB1—Simvastatin—coronary artery disease	0.00186	0.00436	CbGbCtD
Tamoxifen—ABCB1—Lovastatin—coronary artery disease	0.00182	0.00426	CbGbCtD
Tamoxifen—ABCB1—Pravastatin—coronary artery disease	0.00182	0.00426	CbGbCtD
Tamoxifen—CYP2D6—Captopril—coronary artery disease	0.00181	0.00425	CbGbCtD
Tamoxifen—CYP2D6—Simvastatin—coronary artery disease	0.00175	0.0041	CbGbCtD
Tamoxifen—CYP1A2—Losartan—coronary artery disease	0.00173	0.00406	CbGbCtD
Tamoxifen—CYP3A4—Eplerenone—coronary artery disease	0.00173	0.00405	CbGbCtD
Tamoxifen—CYP2D6—Pravastatin—coronary artery disease	0.00171	0.00402	CbGbCtD
Tamoxifen—CYP2D6—Lovastatin—coronary artery disease	0.00171	0.00402	CbGbCtD
Tamoxifen—CYP2C9—Atorvastatin—coronary artery disease	0.0017	0.004	CbGbCtD
Tamoxifen—ABCB1—Atorvastatin—coronary artery disease	0.00165	0.00388	CbGbCtD
Tamoxifen—CYP2C9—Losartan—coronary artery disease	0.00156	0.00366	CbGbCtD
Tamoxifen—CYP2D6—Atorvastatin—coronary artery disease	0.00156	0.00366	CbGbCtD
Tamoxifen—CYP3A4—Enalapril—coronary artery disease	0.00154	0.00361	CbGbCtD
Tamoxifen—ABCB1—Losartan—coronary artery disease	0.00151	0.00355	CbGbCtD
Tamoxifen—CYP3A4—Rosuvastatin—coronary artery disease	0.0012	0.00281	CbGbCtD
Tamoxifen—CYP3A4—Ezetimibe—coronary artery disease	0.0012	0.00281	CbGbCtD
Tamoxifen—CYP3A4—Simvastatin—coronary artery disease	0.00111	0.00261	CbGbCtD
Tamoxifen—CYP3A4—Pravastatin—coronary artery disease	0.00109	0.00255	CbGbCtD
Tamoxifen—CYP3A4—Lovastatin—coronary artery disease	0.00109	0.00255	CbGbCtD
Tamoxifen—CYP3A4—Atorvastatin—coronary artery disease	0.000991	0.00233	CbGbCtD
Tamoxifen—CYP3A4—Losartan—coronary artery disease	0.000907	0.00213	CbGbCtD
Tamoxifen—EBPL—heart—coronary artery disease	0.000805	0.0507	CbGeAlD
Tamoxifen—ESRRA—cardiac ventricle—coronary artery disease	0.000682	0.0429	CbGeAlD
Tamoxifen—ESRRA—myocardium—coronary artery disease	0.000642	0.0404	CbGeAlD
Tamoxifen—SULT1A1—heart—coronary artery disease	0.00064	0.0402	CbGeAlD
Tamoxifen—SULT1A1—blood—coronary artery disease	0.000477	0.03	CbGeAlD
Tamoxifen—DHCR7—heart—coronary artery disease	0.000455	0.0286	CbGeAlD
Tamoxifen—ESRRA—heart—coronary artery disease	0.000448	0.0282	CbGeAlD
Tamoxifen—ESRRA—cardiovascular system—coronary artery disease	0.000423	0.0266	CbGeAlD
Tamoxifen—UGT1A4—blood—coronary artery disease	0.000416	0.0262	CbGeAlD
Tamoxifen—FMO3—heart—coronary artery disease	0.000393	0.0247	CbGeAlD
Tamoxifen—DHCR7—cardiac atrium—coronary artery disease	0.000389	0.0245	CbGeAlD
Tamoxifen—ESRRA—cardiac atrium—coronary artery disease	0.000383	0.0241	CbGeAlD
Tamoxifen—DHCR7—blood—coronary artery disease	0.000339	0.0214	CbGeAlD
Tamoxifen—ESRRA—blood—coronary artery disease	0.000334	0.021	CbGeAlD
Tamoxifen—SIGMAR1—cardiac ventricle—coronary artery disease	0.000317	0.02	CbGeAlD
Tamoxifen—CES1—heart—coronary artery disease	0.00031	0.0195	CbGeAlD
Tamoxifen—SIGMAR1—myocardium—coronary artery disease	0.000298	0.0188	CbGeAlD
Tamoxifen—CES1—cardiovascular system—coronary artery disease	0.000293	0.0184	CbGeAlD
Tamoxifen—ESR2—heart—coronary artery disease	0.000269	0.0169	CbGeAlD
Tamoxifen—ESR2—cardiovascular system—coronary artery disease	0.000254	0.016	CbGeAlD
Tamoxifen—Diethylstilbestrol—ESR2—coronary artery disease	0.000238	0.131	CrCbGaD
Tamoxifen—CES1—blood—coronary artery disease	0.000232	0.0146	CbGeAlD
Tamoxifen—Loperamide—POMC—coronary artery disease	0.000231	0.127	CrCbGaD
Tamoxifen—CYP1A1—cardiac ventricle—coronary artery disease	0.000213	0.0134	CbGeAlD
Tamoxifen—SIGMAR1—heart—coronary artery disease	0.000208	0.0131	CbGeAlD
Tamoxifen—ESR2—blood—coronary artery disease	0.000201	0.0126	CbGeAlD
Tamoxifen—CYP1B1—heart—coronary artery disease	0.000198	0.0125	CbGeAlD
Tamoxifen—CYP1B1—cardiovascular system—coronary artery disease	0.000187	0.0118	CbGeAlD
Tamoxifen—ESR1—heart—coronary artery disease	0.000184	0.0116	CbGeAlD
Tamoxifen—SIGMAR1—cardiac atrium—coronary artery disease	0.000178	0.0112	CbGeAlD
Tamoxifen—ESR1—cardiovascular system—coronary artery disease	0.000174	0.0109	CbGeAlD
Tamoxifen—CYP19A1—blood—coronary artery disease	0.000158	0.00995	CbGeAlD
Tamoxifen—SIGMAR1—blood—coronary artery disease	0.000155	0.00978	CbGeAlD
Tamoxifen—ABCC2—blood—coronary artery disease	0.000151	0.00949	CbGeAlD
Tamoxifen—CYP1B1—blood—coronary artery disease	0.000148	0.0093	CbGeAlD
Tamoxifen—ABCG2—heart—coronary artery disease	0.000147	0.00928	CbGeAlD
Tamoxifen—Diethylstilbestrol—ESR1—coronary artery disease	0.000147	0.0807	CrCbGaD
Tamoxifen—Ospemifene—ESR1—coronary artery disease	0.000143	0.0785	CrCbGaD
Tamoxifen—CYP1A1—heart—coronary artery disease	0.00014	0.00881	CbGeAlD
Tamoxifen—ESR1—blood—coronary artery disease	0.000137	0.00864	CbGeAlD
Tamoxifen—Dextropropoxyphene—OPRD1—coronary artery disease	0.000137	0.075	CrCbGaD
Tamoxifen—CYP2B6—heart—coronary artery disease	0.000136	0.00856	CbGeAlD
Tamoxifen—CYP2C9—heart—coronary artery disease	0.000135	0.00848	CbGeAlD
Tamoxifen—Loperamide—OPRD1—coronary artery disease	0.00013	0.0715	CrCbGaD
Tamoxifen—CYP2C19—blood—coronary artery disease	0.00013	0.00816	CbGeAlD
Tamoxifen—CYP2B6—cardiovascular system—coronary artery disease	0.000128	0.00808	CbGeAlD
Tamoxifen—CYP2C9—cardiovascular system—coronary artery disease	0.000127	0.008	CbGeAlD
Tamoxifen—CYP2E1—cardiovascular system—coronary artery disease	0.00012	0.00758	CbGeAlD
Tamoxifen—CYP1A1—cardiac atrium—coronary artery disease	0.00012	0.00753	CbGeAlD
Tamoxifen—Toremifene—ESR1—coronary artery disease	0.000116	0.064	CrCbGaD
Tamoxifen—Phenoxybenzamine—SLC22A3—coronary artery disease	0.000116	0.0638	CrCbGaD
Tamoxifen—Ospemifene—CYP2C19—coronary artery disease	0.000115	0.063	CrCbGaD
Tamoxifen—CYP2C8—blood—coronary artery disease	0.000113	0.00712	CbGeAlD
Tamoxifen—ABCG2—blood—coronary artery disease	0.00011	0.00692	CbGeAlD
Tamoxifen—CYP1A2—blood—coronary artery disease	0.000106	0.00666	CbGeAlD
Tamoxifen—CYP1A1—blood—coronary artery disease	0.000104	0.00657	CbGeAlD
Tamoxifen—CYP3A5—blood—coronary artery disease	0.000102	0.00643	CbGeAlD
Tamoxifen—CYP2B6—blood—coronary artery disease	0.000102	0.00639	CbGeAlD
Tamoxifen—Clomifene—ESR1—coronary artery disease	0.000101	0.0553	CrCbGaD
Tamoxifen—CYP2C9—blood—coronary artery disease	0.000101	0.00632	CbGeAlD
Tamoxifen—CYP2E1—blood—coronary artery disease	9.53e-05	0.00599	CbGeAlD
Tamoxifen—Methadone—OPRD1—coronary artery disease	9.26e-05	0.0509	CrCbGaD
Tamoxifen—CYP3A4—blood—coronary artery disease	7.66e-05	0.00482	CbGeAlD
Tamoxifen—CYP2D6—blood—coronary artery disease	7.54e-05	0.00475	CbGeAlD
Tamoxifen—ABCB1—heart—coronary artery disease	7.27e-05	0.00457	CbGeAlD
Tamoxifen—ABCB1—cardiovascular system—coronary artery disease	6.86e-05	0.00432	CbGeAlD
Tamoxifen—Cyclobenzaprine—HTR2A—coronary artery disease	6.55e-05	0.036	CrCbGaD
Tamoxifen—ABCB1—blood—coronary artery disease	5.43e-05	0.00341	CbGeAlD
Tamoxifen—Phenoxybenzamine—ADRB2—coronary artery disease	5.31e-05	0.0292	CrCbGaD
Tamoxifen—Diphenhydramine—CYP2C19—coronary artery disease	3.83e-05	0.0211	CrCbGaD
Tamoxifen—Methadone—CYP2C19—coronary artery disease	3.7e-05	0.0203	CrCbGaD
Tamoxifen—Anxiety—Ramipril—coronary artery disease	3.38e-05	0.00028	CcSEcCtD
Tamoxifen—Vomiting—Lovastatin—coronary artery disease	3.38e-05	0.000279	CcSEcCtD
Tamoxifen—Dizziness—Eplerenone—coronary artery disease	3.37e-05	0.000279	CcSEcCtD
Tamoxifen—Rash—Clopidogrel—coronary artery disease	3.37e-05	0.000279	CcSEcCtD
Tamoxifen—Dermatitis—Clopidogrel—coronary artery disease	3.37e-05	0.000279	CcSEcCtD
Tamoxifen—Asthenia—Valsartan—coronary artery disease	3.37e-05	0.000278	CcSEcCtD
Tamoxifen—Hypertension—Timolol—coronary artery disease	3.37e-05	0.000278	CcSEcCtD
Tamoxifen—Pain—Furosemide—coronary artery disease	3.36e-05	0.000278	CcSEcCtD
Tamoxifen—Constipation—Furosemide—coronary artery disease	3.36e-05	0.000278	CcSEcCtD
Tamoxifen—Hypersensitivity—Niacin—coronary artery disease	3.36e-05	0.000278	CcSEcCtD
Tamoxifen—Discomfort—Ramipril—coronary artery disease	3.35e-05	0.000277	CcSEcCtD
Tamoxifen—Asthenia—Olmesartan—coronary artery disease	3.35e-05	0.000277	CcSEcCtD
Tamoxifen—Headache—Clopidogrel—coronary artery disease	3.35e-05	0.000277	CcSEcCtD
Tamoxifen—Rash—Lovastatin—coronary artery disease	3.35e-05	0.000277	CcSEcCtD
Tamoxifen—Dermatitis—Lovastatin—coronary artery disease	3.35e-05	0.000277	CcSEcCtD
Tamoxifen—Anaemia—Lisinopril—coronary artery disease	3.34e-05	0.000276	CcSEcCtD
Tamoxifen—Dyspepsia—Losartan—coronary artery disease	3.34e-05	0.000276	CcSEcCtD
Tamoxifen—Headache—Lovastatin—coronary artery disease	3.33e-05	0.000275	CcSEcCtD
Tamoxifen—Pruritus—Valsartan—coronary artery disease	3.32e-05	0.000274	CcSEcCtD
Tamoxifen—Dry mouth—Ramipril—coronary artery disease	3.32e-05	0.000274	CcSEcCtD
Tamoxifen—Arthralgia—Timolol—coronary artery disease	3.32e-05	0.000274	CcSEcCtD
Tamoxifen—Chest pain—Timolol—coronary artery disease	3.32e-05	0.000274	CcSEcCtD
Tamoxifen—Myalgia—Timolol—coronary artery disease	3.32e-05	0.000274	CcSEcCtD
Tamoxifen—Vomiting—Ezetimibe—coronary artery disease	3.31e-05	0.000274	CcSEcCtD
Tamoxifen—Hypersensitivity—Pravastatin—coronary artery disease	3.31e-05	0.000274	CcSEcCtD
Tamoxifen—Gastrointestinal pain—Perindopril—coronary artery disease	3.31e-05	0.000274	CcSEcCtD
Tamoxifen—Anxiety—Timolol—coronary artery disease	3.31e-05	0.000273	CcSEcCtD
Tamoxifen—Promazine—CYP2C19—coronary artery disease	3.31e-05	0.0182	CrCbGaD
Tamoxifen—Angioedema—Lisinopril—coronary artery disease	3.3e-05	0.000273	CcSEcCtD
Tamoxifen—Pruritus—Olmesartan—coronary artery disease	3.3e-05	0.000273	CcSEcCtD
Tamoxifen—Decreased appetite—Losartan—coronary artery disease	3.3e-05	0.000273	CcSEcCtD
Tamoxifen—Abdominal pain—Captopril—coronary artery disease	3.29e-05	0.000272	CcSEcCtD
Tamoxifen—Dizziness—Simvastatin—coronary artery disease	3.29e-05	0.000272	CcSEcCtD
Tamoxifen—Rash—Ezetimibe—coronary artery disease	3.29e-05	0.000272	CcSEcCtD
Tamoxifen—Dermatitis—Ezetimibe—coronary artery disease	3.28e-05	0.000271	CcSEcCtD
Tamoxifen—Discomfort—Timolol—coronary artery disease	3.28e-05	0.000271	CcSEcCtD
Tamoxifen—Asthenia—Niacin—coronary artery disease	3.27e-05	0.000271	CcSEcCtD
Tamoxifen—Fatigue—Losartan—coronary artery disease	3.27e-05	0.000271	CcSEcCtD
Tamoxifen—Headache—Ezetimibe—coronary artery disease	3.26e-05	0.00027	CcSEcCtD
Tamoxifen—Oedema—Ramipril—coronary artery disease	3.25e-05	0.000269	CcSEcCtD
Tamoxifen—Dry mouth—Timolol—coronary artery disease	3.25e-05	0.000268	CcSEcCtD
Tamoxifen—Constipation—Losartan—coronary artery disease	3.25e-05	0.000268	CcSEcCtD
Tamoxifen—Pain—Losartan—coronary artery disease	3.25e-05	0.000268	CcSEcCtD
Tamoxifen—Vomiting—Eplerenone—coronary artery disease	3.24e-05	0.000268	CcSEcCtD
Tamoxifen—Leukopenia—Lisinopril—coronary artery disease	3.24e-05	0.000268	CcSEcCtD
Tamoxifen—Nausea—Fenofibrate—coronary artery disease	3.23e-05	0.000267	CcSEcCtD
Tamoxifen—Pruritus—Niacin—coronary artery disease	3.23e-05	0.000267	CcSEcCtD
Tamoxifen—Asthenia—Pravastatin—coronary artery disease	3.22e-05	0.000266	CcSEcCtD
Tamoxifen—Gastrointestinal pain—Furosemide—coronary artery disease	3.22e-05	0.000266	CcSEcCtD
Tamoxifen—Rash—Eplerenone—coronary artery disease	3.22e-05	0.000266	CcSEcCtD
Tamoxifen—Urticaria—Perindopril—coronary artery disease	3.21e-05	0.000266	CcSEcCtD
Tamoxifen—Hypersensitivity—Trandolapril—coronary artery disease	3.21e-05	0.000266	CcSEcCtD
Tamoxifen—Dermatitis—Eplerenone—coronary artery disease	3.21e-05	0.000266	CcSEcCtD
Tamoxifen—Diarrhoea—Valsartan—coronary artery disease	3.21e-05	0.000265	CcSEcCtD
Tamoxifen—Hypersensitivity—Enalapril—coronary artery disease	3.2e-05	0.000265	CcSEcCtD
Tamoxifen—Abdominal pain—Perindopril—coronary artery disease	3.2e-05	0.000264	CcSEcCtD
Tamoxifen—Diarrhoea—Olmesartan—coronary artery disease	3.2e-05	0.000264	CcSEcCtD
Tamoxifen—Headache—Eplerenone—coronary artery disease	3.19e-05	0.000264	CcSEcCtD
Tamoxifen—Thrombocytopenia—Ramipril—coronary artery disease	3.19e-05	0.000263	CcSEcCtD
Tamoxifen—Oedema—Timolol—coronary artery disease	3.18e-05	0.000263	CcSEcCtD
Tamoxifen—Pruritus—Pravastatin—coronary artery disease	3.18e-05	0.000263	CcSEcCtD
Tamoxifen—Nausea—Clopidogrel—coronary artery disease	3.18e-05	0.000263	CcSEcCtD
Tamoxifen—Infection—Timolol—coronary artery disease	3.16e-05	0.000261	CcSEcCtD
Tamoxifen—Vomiting—Simvastatin—coronary artery disease	3.16e-05	0.000261	CcSEcCtD
Tamoxifen—Hypersensitivity—Telmisartan—coronary artery disease	3.16e-05	0.000261	CcSEcCtD
Tamoxifen—Cough—Lisinopril—coronary artery disease	3.16e-05	0.000261	CcSEcCtD
Tamoxifen—Nausea—Lovastatin—coronary artery disease	3.16e-05	0.000261	CcSEcCtD
Tamoxifen—Hyperhidrosis—Ramipril—coronary artery disease	3.15e-05	0.00026	CcSEcCtD
Tamoxifen—Rash—Simvastatin—coronary artery disease	3.13e-05	0.000259	CcSEcCtD
Tamoxifen—Dermatitis—Simvastatin—coronary artery disease	3.13e-05	0.000259	CcSEcCtD
Tamoxifen—Asthenia—Trandolapril—coronary artery disease	3.13e-05	0.000259	CcSEcCtD
Tamoxifen—Urticaria—Furosemide—coronary artery disease	3.12e-05	0.000258	CcSEcCtD
Tamoxifen—Diarrhoea—Niacin—coronary artery disease	3.12e-05	0.000258	CcSEcCtD
Tamoxifen—Asthenia—Enalapril—coronary artery disease	3.12e-05	0.000258	CcSEcCtD
Tamoxifen—Headache—Simvastatin—coronary artery disease	3.11e-05	0.000257	CcSEcCtD
Tamoxifen—Abdominal pain—Furosemide—coronary artery disease	3.11e-05	0.000257	CcSEcCtD
Tamoxifen—Gastrointestinal pain—Losartan—coronary artery disease	3.1e-05	0.000257	CcSEcCtD
Tamoxifen—Dizziness—Valsartan—coronary artery disease	3.1e-05	0.000257	CcSEcCtD
Tamoxifen—Anorexia—Ramipril—coronary artery disease	3.1e-05	0.000256	CcSEcCtD
Tamoxifen—Nausea—Ezetimibe—coronary artery disease	3.09e-05	0.000256	CcSEcCtD
Tamoxifen—Dizziness—Olmesartan—coronary artery disease	3.09e-05	0.000255	CcSEcCtD
Tamoxifen—Pruritus—Trandolapril—coronary artery disease	3.09e-05	0.000255	CcSEcCtD
Tamoxifen—Myalgia—Lisinopril—coronary artery disease	3.08e-05	0.000255	CcSEcCtD
Tamoxifen—Arthralgia—Lisinopril—coronary artery disease	3.08e-05	0.000255	CcSEcCtD
Tamoxifen—Chest pain—Lisinopril—coronary artery disease	3.08e-05	0.000255	CcSEcCtD
Tamoxifen—Hyperhidrosis—Timolol—coronary artery disease	3.08e-05	0.000254	CcSEcCtD
Tamoxifen—Asthenia—Telmisartan—coronary artery disease	3.07e-05	0.000254	CcSEcCtD
Tamoxifen—Pruritus—Enalapril—coronary artery disease	3.07e-05	0.000254	CcSEcCtD
Tamoxifen—Diarrhoea—Pravastatin—coronary artery disease	3.07e-05	0.000254	CcSEcCtD
Tamoxifen—Anxiety—Lisinopril—coronary artery disease	3.07e-05	0.000254	CcSEcCtD
Tamoxifen—Discomfort—Lisinopril—coronary artery disease	3.04e-05	0.000251	CcSEcCtD
Tamoxifen—Anorexia—Timolol—coronary artery disease	3.03e-05	0.000251	CcSEcCtD
Tamoxifen—Pruritus—Telmisartan—coronary artery disease	3.03e-05	0.000251	CcSEcCtD
Tamoxifen—Nausea—Eplerenone—coronary artery disease	3.03e-05	0.00025	CcSEcCtD
Tamoxifen—Dizziness—Niacin—coronary artery disease	3.02e-05	0.000249	CcSEcCtD
Tamoxifen—Urticaria—Losartan—coronary artery disease	3.01e-05	0.000249	CcSEcCtD
Tamoxifen—Dry mouth—Lisinopril—coronary artery disease	3.01e-05	0.000249	CcSEcCtD
Tamoxifen—Abdominal pain—Losartan—coronary artery disease	3e-05	0.000248	CcSEcCtD
Tamoxifen—Asthenia—Captopril—coronary artery disease	2.99e-05	0.000247	CcSEcCtD
Tamoxifen—Diarrhoea—Trandolapril—coronary artery disease	2.98e-05	0.000247	CcSEcCtD
Tamoxifen—Vomiting—Valsartan—coronary artery disease	2.98e-05	0.000247	CcSEcCtD
Tamoxifen—Diarrhoea—Enalapril—coronary artery disease	2.97e-05	0.000246	CcSEcCtD
Tamoxifen—Dizziness—Pravastatin—coronary artery disease	2.97e-05	0.000246	CcSEcCtD
Tamoxifen—Vomiting—Olmesartan—coronary artery disease	2.97e-05	0.000245	CcSEcCtD
Tamoxifen—Musculoskeletal discomfort—Ramipril—coronary artery disease	2.96e-05	0.000245	CcSEcCtD
Tamoxifen—Rash—Valsartan—coronary artery disease	2.96e-05	0.000245	CcSEcCtD
Tamoxifen—Dermatitis—Valsartan—coronary artery disease	2.96e-05	0.000244	CcSEcCtD
Tamoxifen—Nausea—Simvastatin—coronary artery disease	2.95e-05	0.000244	CcSEcCtD
Tamoxifen—Oedema—Lisinopril—coronary artery disease	2.95e-05	0.000244	CcSEcCtD
Tamoxifen—Pruritus—Captopril—coronary artery disease	2.95e-05	0.000244	CcSEcCtD
Tamoxifen—Rash—Olmesartan—coronary artery disease	2.94e-05	0.000243	CcSEcCtD
Tamoxifen—Insomnia—Ramipril—coronary artery disease	2.94e-05	0.000243	CcSEcCtD
Tamoxifen—Dermatitis—Olmesartan—coronary artery disease	2.94e-05	0.000243	CcSEcCtD
Tamoxifen—Headache—Valsartan—coronary artery disease	2.94e-05	0.000243	CcSEcCtD
Tamoxifen—Diarrhoea—Telmisartan—coronary artery disease	2.93e-05	0.000242	CcSEcCtD
Tamoxifen—Infection—Lisinopril—coronary artery disease	2.93e-05	0.000242	CcSEcCtD
Tamoxifen—Headache—Olmesartan—coronary artery disease	2.93e-05	0.000242	CcSEcCtD
Tamoxifen—Paraesthesia—Ramipril—coronary artery disease	2.92e-05	0.000242	CcSEcCtD
Tamoxifen—Asthenia—Perindopril—coronary artery disease	2.9e-05	0.00024	CcSEcCtD
Tamoxifen—Dyspnoea—Ramipril—coronary artery disease	2.9e-05	0.00024	CcSEcCtD
Tamoxifen—Vomiting—Niacin—coronary artery disease	2.9e-05	0.00024	CcSEcCtD
Tamoxifen—Musculoskeletal discomfort—Timolol—coronary artery disease	2.9e-05	0.00024	CcSEcCtD
Tamoxifen—Hypersensitivity—Furosemide—coronary artery disease	2.9e-05	0.00024	CcSEcCtD
Tamoxifen—Thrombocytopenia—Lisinopril—coronary artery disease	2.89e-05	0.000239	CcSEcCtD
Tamoxifen—Dizziness—Trandolapril—coronary artery disease	2.88e-05	0.000238	CcSEcCtD
Tamoxifen—Insomnia—Timolol—coronary artery disease	2.88e-05	0.000238	CcSEcCtD
Tamoxifen—Rash—Niacin—coronary artery disease	2.88e-05	0.000238	CcSEcCtD
Tamoxifen—Dermatitis—Niacin—coronary artery disease	2.87e-05	0.000238	CcSEcCtD
Tamoxifen—Dizziness—Enalapril—coronary artery disease	2.87e-05	0.000238	CcSEcCtD
Tamoxifen—Dyspepsia—Ramipril—coronary artery disease	2.86e-05	0.000237	CcSEcCtD
Tamoxifen—Pruritus—Perindopril—coronary artery disease	2.86e-05	0.000237	CcSEcCtD
Tamoxifen—Headache—Niacin—coronary artery disease	2.86e-05	0.000236	CcSEcCtD
Tamoxifen—Paraesthesia—Timolol—coronary artery disease	2.86e-05	0.000236	CcSEcCtD
Tamoxifen—Vomiting—Pravastatin—coronary artery disease	2.86e-05	0.000236	CcSEcCtD
Tamoxifen—Hyperhidrosis—Lisinopril—coronary artery disease	2.85e-05	0.000236	CcSEcCtD
Tamoxifen—Diarrhoea—Captopril—coronary artery disease	2.85e-05	0.000236	CcSEcCtD
Tamoxifen—Dyspnoea—Timolol—coronary artery disease	2.84e-05	0.000234	CcSEcCtD
Tamoxifen—Dizziness—Telmisartan—coronary artery disease	2.83e-05	0.000234	CcSEcCtD
Tamoxifen—Rash—Pravastatin—coronary artery disease	2.83e-05	0.000234	CcSEcCtD
Tamoxifen—Dermatitis—Pravastatin—coronary artery disease	2.83e-05	0.000234	CcSEcCtD
Tamoxifen—Decreased appetite—Ramipril—coronary artery disease	2.83e-05	0.000234	CcSEcCtD
Tamoxifen—Asthenia—Furosemide—coronary artery disease	2.82e-05	0.000233	CcSEcCtD
Tamoxifen—Headache—Pravastatin—coronary artery disease	2.81e-05	0.000233	CcSEcCtD
Tamoxifen—Anorexia—Lisinopril—coronary artery disease	2.81e-05	0.000233	CcSEcCtD
Tamoxifen—Gastrointestinal disorder—Ramipril—coronary artery disease	2.81e-05	0.000232	CcSEcCtD
Tamoxifen—Fatigue—Ramipril—coronary artery disease	2.81e-05	0.000232	CcSEcCtD
Tamoxifen—Dyspepsia—Timolol—coronary artery disease	2.8e-05	0.000232	CcSEcCtD
Tamoxifen—Hypersensitivity—Losartan—coronary artery disease	2.8e-05	0.000231	CcSEcCtD
Tamoxifen—Nausea—Valsartan—coronary artery disease	2.79e-05	0.00023	CcSEcCtD
Tamoxifen—Pruritus—Furosemide—coronary artery disease	2.78e-05	0.00023	CcSEcCtD
Tamoxifen—Constipation—Ramipril—coronary artery disease	2.78e-05	0.00023	CcSEcCtD
Tamoxifen—Nausea—Olmesartan—coronary artery disease	2.77e-05	0.000229	CcSEcCtD
Tamoxifen—Vomiting—Trandolapril—coronary artery disease	2.77e-05	0.000229	CcSEcCtD
Tamoxifen—Diarrhoea—Perindopril—coronary artery disease	2.77e-05	0.000229	CcSEcCtD
Tamoxifen—Decreased appetite—Timolol—coronary artery disease	2.77e-05	0.000229	CcSEcCtD
Tamoxifen—Vomiting—Enalapril—coronary artery disease	2.76e-05	0.000228	CcSEcCtD
Tamoxifen—Dizziness—Captopril—coronary artery disease	2.76e-05	0.000228	CcSEcCtD
Tamoxifen—Rash—Trandolapril—coronary artery disease	2.75e-05	0.000227	CcSEcCtD
Tamoxifen—Dermatitis—Trandolapril—coronary artery disease	2.75e-05	0.000227	CcSEcCtD
Tamoxifen—Gastrointestinal disorder—Timolol—coronary artery disease	2.75e-05	0.000227	CcSEcCtD
Tamoxifen—Fatigue—Timolol—coronary artery disease	2.74e-05	0.000227	CcSEcCtD
Tamoxifen—Rash—Enalapril—coronary artery disease	2.74e-05	0.000226	CcSEcCtD
Tamoxifen—Dermatitis—Enalapril—coronary artery disease	2.74e-05	0.000226	CcSEcCtD
Tamoxifen—Headache—Trandolapril—coronary artery disease	2.73e-05	0.000226	CcSEcCtD
Tamoxifen—Vomiting—Telmisartan—coronary artery disease	2.72e-05	0.000225	CcSEcCtD
Tamoxifen—Asthenia—Losartan—coronary artery disease	2.72e-05	0.000225	CcSEcCtD
Tamoxifen—Headache—Enalapril—coronary artery disease	2.72e-05	0.000225	CcSEcCtD
Tamoxifen—Pain—Timolol—coronary artery disease	2.72e-05	0.000225	CcSEcCtD
Tamoxifen—Nausea—Niacin—coronary artery disease	2.71e-05	0.000224	CcSEcCtD
Tamoxifen—Rash—Telmisartan—coronary artery disease	2.7e-05	0.000223	CcSEcCtD
Tamoxifen—Dermatitis—Telmisartan—coronary artery disease	2.7e-05	0.000223	CcSEcCtD
Tamoxifen—Diarrhoea—Furosemide—coronary artery disease	2.69e-05	0.000222	CcSEcCtD
Tamoxifen—Musculoskeletal discomfort—Lisinopril—coronary artery disease	2.69e-05	0.000222	CcSEcCtD
Tamoxifen—Pruritus—Losartan—coronary artery disease	2.68e-05	0.000222	CcSEcCtD
Tamoxifen—Headache—Telmisartan—coronary artery disease	2.68e-05	0.000222	CcSEcCtD
Tamoxifen—Promazine—HTR2A—coronary artery disease	2.68e-05	0.0147	CrCbGaD
Tamoxifen—Dizziness—Perindopril—coronary artery disease	2.68e-05	0.000221	CcSEcCtD
Tamoxifen—Insomnia—Lisinopril—coronary artery disease	2.67e-05	0.000221	CcSEcCtD
Tamoxifen—Nausea—Pravastatin—coronary artery disease	2.67e-05	0.000221	CcSEcCtD
Tamoxifen—Gastrointestinal pain—Ramipril—coronary artery disease	2.66e-05	0.00022	CcSEcCtD
Tamoxifen—Paraesthesia—Lisinopril—coronary artery disease	2.65e-05	0.000219	CcSEcCtD
Tamoxifen—Vomiting—Captopril—coronary artery disease	2.65e-05	0.000219	CcSEcCtD
Tamoxifen—Dyspnoea—Lisinopril—coronary artery disease	2.63e-05	0.000218	CcSEcCtD
Tamoxifen—Rash—Captopril—coronary artery disease	2.63e-05	0.000217	CcSEcCtD
Tamoxifen—Dermatitis—Captopril—coronary artery disease	2.62e-05	0.000217	CcSEcCtD
Tamoxifen—Headache—Captopril—coronary artery disease	2.61e-05	0.000216	CcSEcCtD
Tamoxifen—Gastrointestinal pain—Timolol—coronary artery disease	2.6e-05	0.000215	CcSEcCtD
Tamoxifen—Dizziness—Furosemide—coronary artery disease	2.6e-05	0.000215	CcSEcCtD
Tamoxifen—Dyspepsia—Lisinopril—coronary artery disease	2.6e-05	0.000215	CcSEcCtD
Tamoxifen—Diarrhoea—Losartan—coronary artery disease	2.6e-05	0.000215	CcSEcCtD
Tamoxifen—Nausea—Trandolapril—coronary artery disease	2.59e-05	0.000214	CcSEcCtD
Tamoxifen—Urticaria—Ramipril—coronary artery disease	2.59e-05	0.000214	CcSEcCtD
Tamoxifen—Nausea—Enalapril—coronary artery disease	2.58e-05	0.000213	CcSEcCtD
Tamoxifen—Vomiting—Perindopril—coronary artery disease	2.57e-05	0.000213	CcSEcCtD
Tamoxifen—Abdominal pain—Ramipril—coronary artery disease	2.57e-05	0.000213	CcSEcCtD
Tamoxifen—Decreased appetite—Lisinopril—coronary artery disease	2.57e-05	0.000212	CcSEcCtD
Tamoxifen—Rash—Perindopril—coronary artery disease	2.55e-05	0.000211	CcSEcCtD
Tamoxifen—Dermatitis—Perindopril—coronary artery disease	2.55e-05	0.000211	CcSEcCtD
Tamoxifen—Gastrointestinal disorder—Lisinopril—coronary artery disease	2.55e-05	0.000211	CcSEcCtD
Tamoxifen—Nausea—Telmisartan—coronary artery disease	2.55e-05	0.00021	CcSEcCtD
Tamoxifen—Fatigue—Lisinopril—coronary artery disease	2.54e-05	0.00021	CcSEcCtD
Tamoxifen—Headache—Perindopril—coronary artery disease	2.53e-05	0.00021	CcSEcCtD
Tamoxifen—Urticaria—Timolol—coronary artery disease	2.53e-05	0.000209	CcSEcCtD
Tamoxifen—Constipation—Lisinopril—coronary artery disease	2.52e-05	0.000209	CcSEcCtD
Tamoxifen—Pain—Lisinopril—coronary artery disease	2.52e-05	0.000209	CcSEcCtD
Tamoxifen—Abdominal pain—Timolol—coronary artery disease	2.51e-05	0.000208	CcSEcCtD
Tamoxifen—Dizziness—Losartan—coronary artery disease	2.51e-05	0.000207	CcSEcCtD
Tamoxifen—Vomiting—Furosemide—coronary artery disease	2.5e-05	0.000207	CcSEcCtD
Tamoxifen—Rash—Furosemide—coronary artery disease	2.48e-05	0.000205	CcSEcCtD
Tamoxifen—Dermatitis—Furosemide—coronary artery disease	2.48e-05	0.000205	CcSEcCtD
Tamoxifen—Nausea—Captopril—coronary artery disease	2.48e-05	0.000205	CcSEcCtD
Tamoxifen—Headache—Furosemide—coronary artery disease	2.46e-05	0.000204	CcSEcCtD
Tamoxifen—Gastrointestinal pain—Lisinopril—coronary artery disease	2.41e-05	0.0002	CcSEcCtD
Tamoxifen—Vomiting—Losartan—coronary artery disease	2.41e-05	0.000199	CcSEcCtD
Tamoxifen—Nausea—Perindopril—coronary artery disease	2.4e-05	0.000199	CcSEcCtD
Tamoxifen—Hypersensitivity—Ramipril—coronary artery disease	2.4e-05	0.000198	CcSEcCtD
Tamoxifen—Rash—Losartan—coronary artery disease	2.39e-05	0.000198	CcSEcCtD
Tamoxifen—Dermatitis—Losartan—coronary artery disease	2.39e-05	0.000198	CcSEcCtD
Tamoxifen—Headache—Losartan—coronary artery disease	2.38e-05	0.000197	CcSEcCtD
Tamoxifen—Urticaria—Lisinopril—coronary artery disease	2.34e-05	0.000194	CcSEcCtD
Tamoxifen—Hypersensitivity—Timolol—coronary artery disease	2.34e-05	0.000194	CcSEcCtD
Tamoxifen—Nausea—Furosemide—coronary artery disease	2.34e-05	0.000193	CcSEcCtD
Tamoxifen—Asthenia—Ramipril—coronary artery disease	2.33e-05	0.000193	CcSEcCtD
Tamoxifen—Abdominal pain—Lisinopril—coronary artery disease	2.33e-05	0.000193	CcSEcCtD
Tamoxifen—Pruritus—Ramipril—coronary artery disease	2.3e-05	0.00019	CcSEcCtD
Tamoxifen—Asthenia—Timolol—coronary artery disease	2.28e-05	0.000189	CcSEcCtD
Tamoxifen—Nausea—Losartan—coronary artery disease	2.25e-05	0.000186	CcSEcCtD
Tamoxifen—Pruritus—Timolol—coronary artery disease	2.25e-05	0.000186	CcSEcCtD
Tamoxifen—Diarrhoea—Ramipril—coronary artery disease	2.23e-05	0.000184	CcSEcCtD
Tamoxifen—Diarrhoea—Timolol—coronary artery disease	2.18e-05	0.00018	CcSEcCtD
Tamoxifen—Hypersensitivity—Lisinopril—coronary artery disease	2.17e-05	0.00018	CcSEcCtD
Tamoxifen—Dizziness—Ramipril—coronary artery disease	2.15e-05	0.000178	CcSEcCtD
Tamoxifen—Asthenia—Lisinopril—coronary artery disease	2.12e-05	0.000175	CcSEcCtD
Tamoxifen—Dizziness—Timolol—coronary artery disease	2.1e-05	0.000174	CcSEcCtD
Tamoxifen—Pruritus—Lisinopril—coronary artery disease	2.09e-05	0.000173	CcSEcCtD
Tamoxifen—Vomiting—Ramipril—coronary artery disease	2.07e-05	0.000171	CcSEcCtD
Tamoxifen—Rash—Ramipril—coronary artery disease	2.05e-05	0.00017	CcSEcCtD
Tamoxifen—Dermatitis—Ramipril—coronary artery disease	2.05e-05	0.000169	CcSEcCtD
Tamoxifen—Headache—Ramipril—coronary artery disease	2.04e-05	0.000169	CcSEcCtD
Tamoxifen—Vomiting—Timolol—coronary artery disease	2.02e-05	0.000167	CcSEcCtD
Tamoxifen—Diarrhoea—Lisinopril—coronary artery disease	2.02e-05	0.000167	CcSEcCtD
Tamoxifen—Rash—Timolol—coronary artery disease	2.01e-05	0.000166	CcSEcCtD
Tamoxifen—Dermatitis—Timolol—coronary artery disease	2e-05	0.000166	CcSEcCtD
Tamoxifen—Headache—Timolol—coronary artery disease	1.99e-05	0.000165	CcSEcCtD
Tamoxifen—Dizziness—Lisinopril—coronary artery disease	1.95e-05	0.000161	CcSEcCtD
Tamoxifen—Nausea—Ramipril—coronary artery disease	1.93e-05	0.00016	CcSEcCtD
Tamoxifen—Nausea—Timolol—coronary artery disease	1.89e-05	0.000156	CcSEcCtD
Tamoxifen—Vomiting—Lisinopril—coronary artery disease	1.88e-05	0.000155	CcSEcCtD
Tamoxifen—Rash—Lisinopril—coronary artery disease	1.86e-05	0.000154	CcSEcCtD
Tamoxifen—Dermatitis—Lisinopril—coronary artery disease	1.86e-05	0.000154	CcSEcCtD
Tamoxifen—Headache—Lisinopril—coronary artery disease	1.85e-05	0.000153	CcSEcCtD
Tamoxifen—Nausea—Lisinopril—coronary artery disease	1.75e-05	0.000145	CcSEcCtD
Tamoxifen—CYP2B6—Metabolism—APOE—coronary artery disease	8.91e-07	1.01e-05	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—AGT—coronary artery disease	8.9e-07	1.01e-05	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—GSTP1—coronary artery disease	8.9e-07	1.01e-05	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—AGT—coronary artery disease	8.88e-07	1.01e-05	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—MTHFR—coronary artery disease	8.83e-07	1e-05	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—PPARGC1A—coronary artery disease	8.82e-07	1e-05	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—APOA1—coronary artery disease	8.8e-07	1e-05	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—HMOX1—coronary artery disease	8.78e-07	9.97e-06	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—GPX1—coronary artery disease	8.78e-07	9.97e-06	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—CCL2—coronary artery disease	8.73e-07	9.91e-06	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—APOE—coronary artery disease	8.72e-07	9.91e-06	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—APOE—coronary artery disease	8.7e-07	9.89e-06	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—IL6R—coronary artery disease	8.7e-07	9.88e-06	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—GSTP1—coronary artery disease	8.69e-07	9.87e-06	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—VCAN—coronary artery disease	8.66e-07	9.84e-06	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—CAT—coronary artery disease	8.66e-07	9.84e-06	CbGpPWpGaD
Tamoxifen—CYP2A6—Metabolism—ALB—coronary artery disease	8.64e-07	9.82e-06	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—APOA1—coronary artery disease	8.62e-07	9.8e-06	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—PPARGC1A—coronary artery disease	8.61e-07	9.78e-06	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—APOA1—coronary artery disease	8.61e-07	9.78e-06	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—ALDOA—coronary artery disease	8.6e-07	9.77e-06	CbGpPWpGaD
Tamoxifen—UGT1A4—Metabolism—AKT1—coronary artery disease	8.59e-07	9.75e-06	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—IGF1—coronary artery disease	8.58e-07	9.75e-06	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—HMOX1—coronary artery disease	8.57e-07	9.73e-06	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—CD36—coronary artery disease	8.55e-07	9.71e-06	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—CAT—coronary artery disease	8.45e-07	9.6e-06	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—PPP2CA—coronary artery disease	8.44e-07	9.59e-06	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—APOB—coronary artery disease	8.41e-07	9.55e-06	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—AGT—coronary artery disease	8.39e-07	9.54e-06	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—DCN—coronary artery disease	8.35e-07	9.48e-06	CbGpPWpGaD
Tamoxifen—ABCG2—Metabolism—PTGS2—coronary artery disease	8.32e-07	9.46e-06	CbGpPWpGaD
Tamoxifen—CYP2A6—Metabolism—NOS3—coronary artery disease	8.27e-07	9.39e-06	CbGpPWpGaD
Tamoxifen—CYP3A7—Metabolism—PTGS2—coronary artery disease	8.25e-07	9.37e-06	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—PLCB1—coronary artery disease	8.22e-07	9.34e-06	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—APOE—coronary artery disease	8.22e-07	9.34e-06	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—APOB—coronary artery disease	8.21e-07	9.32e-06	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—GSTP1—coronary artery disease	8.19e-07	9.3e-06	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—GSTM1—coronary artery disease	8.18e-07	9.29e-06	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—SERPINE1—coronary artery disease	8.15e-07	9.25e-06	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—APOA1—coronary artery disease	8.13e-07	9.24e-06	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—ALDH2—coronary artery disease	8.12e-07	9.22e-06	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—GSTP1—coronary artery disease	8.12e-07	9.22e-06	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—PPARGC1A—coronary artery disease	8.11e-07	9.21e-06	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—MTHFR—coronary artery disease	8.1e-07	9.2e-06	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—HMOX1—coronary artery disease	8.07e-07	9.17e-06	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—coronary artery disease	8.07e-07	9.17e-06	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—PPARGC1A—coronary artery disease	8.04e-07	9.13e-06	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—LPL—coronary artery disease	8.03e-07	9.12e-06	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—HMOX1—coronary artery disease	8e-07	9.09e-06	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—GSTM1—coronary artery disease	7.98e-07	9.07e-06	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—ABCA1—coronary artery disease	7.97e-07	9.06e-06	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—CAT—coronary artery disease	7.97e-07	9.05e-06	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—LIPC—coronary artery disease	7.91e-07	8.99e-06	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—HBA1—coronary artery disease	7.91e-07	8.99e-06	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—CYP2C19—coronary artery disease	7.91e-07	8.99e-06	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—PIK3C2A—coronary artery disease	7.91e-07	8.99e-06	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—CAT—coronary artery disease	7.9e-07	8.97e-06	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—FGF2—coronary artery disease	7.89e-07	8.96e-06	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—APOC3—coronary artery disease	7.86e-07	8.93e-06	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—LPL—coronary artery disease	7.84e-07	8.9e-06	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—GPX1—coronary artery disease	7.83e-07	8.9e-06	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—LDLR—coronary artery disease	7.81e-07	8.88e-06	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	7.78e-07	8.84e-06	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—NOS3—coronary artery disease	7.78e-07	8.84e-06	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—PPARG—coronary artery disease	7.76e-07	8.81e-06	CbGpPWpGaD
Tamoxifen—ABCB11—Metabolism—PIK3CA—coronary artery disease	7.75e-07	8.8e-06	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—APOB—coronary artery disease	7.73e-07	8.79e-06	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—GSTT1—coronary artery disease	7.72e-07	8.77e-06	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—SLC9A1—coronary artery disease	7.72e-07	8.77e-06	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—GOT1—coronary artery disease	7.72e-07	8.77e-06	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—GGT1—coronary artery disease	7.72e-07	8.77e-06	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—AGT—coronary artery disease	7.7e-07	8.74e-06	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—APOB—coronary artery disease	7.67e-07	8.71e-06	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—POMC—coronary artery disease	7.65e-07	8.69e-06	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—GPX1—coronary artery disease	7.65e-07	8.69e-06	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—GCLC—coronary artery disease	7.63e-07	8.67e-06	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—CETP—coronary artery disease	7.63e-07	8.67e-06	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—CD36—coronary artery disease	7.63e-07	8.67e-06	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—PPARG—coronary artery disease	7.6e-07	8.63e-06	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—PPARG—coronary artery disease	7.58e-07	8.61e-06	CbGpPWpGaD
Tamoxifen—CYP2A6—Metabolism—PTGS2—coronary artery disease	7.56e-07	8.59e-06	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—JAK2—coronary artery disease	7.56e-07	8.59e-06	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—SDC1—coronary artery disease	7.55e-07	8.57e-06	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—APOE—coronary artery disease	7.54e-07	8.57e-06	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—PPP2CA—coronary artery disease	7.53e-07	8.56e-06	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—GSTM1—coronary artery disease	7.52e-07	8.55e-06	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—POMC—coronary artery disease	7.49e-07	8.51e-06	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—POMC—coronary artery disease	7.48e-07	8.5e-06	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—GSTM1—coronary artery disease	7.46e-07	8.47e-06	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—APOA1—coronary artery disease	7.45e-07	8.47e-06	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—CD36—coronary artery disease	7.45e-07	8.46e-06	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—LPL—coronary artery disease	7.38e-07	8.39e-06	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—PPP2CA—coronary artery disease	7.35e-07	8.35e-06	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—LPL—coronary artery disease	7.32e-07	8.32e-06	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—MTHFR—coronary artery disease	7.23e-07	8.21e-06	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—GPX1—coronary artery disease	7.2e-07	8.18e-06	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—PPARG—coronary artery disease	7.16e-07	8.14e-06	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—GPX1—coronary artery disease	7.14e-07	8.11e-06	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	7.14e-07	8.11e-06	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—PSMB5—coronary artery disease	7.13e-07	8.1e-06	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—PSMA6—coronary artery disease	7.13e-07	8.1e-06	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—POMC—coronary artery disease	7.06e-07	8.03e-06	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—MTHFR—coronary artery disease	7.06e-07	8.02e-06	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—CD36—coronary artery disease	7.02e-07	7.97e-06	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—ALB—coronary artery disease	6.98e-07	7.92e-06	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—CTGF—coronary artery disease	6.97e-07	7.91e-06	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—CD36—coronary artery disease	6.96e-07	7.9e-06	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—GSTP1—coronary artery disease	6.94e-07	7.88e-06	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—PPP2CA—coronary artery disease	6.93e-07	7.87e-06	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—GOT2—coronary artery disease	6.9e-07	7.84e-06	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—HMGCR—coronary artery disease	6.9e-07	7.84e-06	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—CXCL8—coronary artery disease	6.9e-07	7.84e-06	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—PPARGC1A—coronary artery disease	6.87e-07	7.81e-06	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—PPP2CA—coronary artery disease	6.87e-07	7.8e-06	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—AGT—coronary artery disease	6.87e-07	7.8e-06	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—HMOX1—coronary artery disease	6.84e-07	7.77e-06	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—ALB—coronary artery disease	6.83e-07	7.76e-06	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—ALB—coronary artery disease	6.82e-07	7.75e-06	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—CAT—coronary artery disease	6.75e-07	7.67e-06	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—APOE—coronary artery disease	6.73e-07	7.65e-06	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—AGT—coronary artery disease	6.7e-07	7.62e-06	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—NOS3—coronary artery disease	6.67e-07	7.58e-06	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—APOA1—coronary artery disease	6.65e-07	7.56e-06	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—MTHFR—coronary artery disease	6.65e-07	7.55e-06	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—CASP3—coronary artery disease	6.6e-07	7.5e-06	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—MTHFR—coronary artery disease	6.59e-07	7.49e-06	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—APOE—coronary artery disease	6.57e-07	7.46e-06	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—PPARG—coronary artery disease	6.57e-07	7.46e-06	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—APOB—coronary artery disease	6.55e-07	7.44e-06	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—NOS3—coronary artery disease	6.53e-07	7.42e-06	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—NOS3—coronary artery disease	6.52e-07	7.41e-06	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—APOA1—coronary artery disease	6.49e-07	7.38e-06	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—POMC—coronary artery disease	6.48e-07	7.36e-06	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—ALB—coronary artery disease	6.44e-07	7.32e-06	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—CCND1—coronary artery disease	6.43e-07	7.3e-06	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—GSTM1—coronary artery disease	6.37e-07	7.24e-06	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	6.37e-07	7.24e-06	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—PLCB1—coronary artery disease	6.35e-07	7.21e-06	CbGpPWpGaD
Tamoxifen—ABCB11—Metabolism—AKT1—coronary artery disease	6.33e-07	7.19e-06	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—AGT—coronary artery disease	6.32e-07	7.18e-06	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—AGT—coronary artery disease	6.26e-07	7.11e-06	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—LPL—coronary artery disease	6.26e-07	7.11e-06	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—MMP9—coronary artery disease	6.24e-07	7.09e-06	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—APOE—coronary artery disease	6.19e-07	7.03e-06	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—NOS3—coronary artery disease	6.16e-07	7e-06	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—ABCA1—coronary artery disease	6.15e-07	6.99e-06	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—APOE—coronary artery disease	6.14e-07	6.97e-06	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—APOA1—coronary artery disease	6.12e-07	6.95e-06	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—GPX1—coronary artery disease	6.1e-07	6.93e-06	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—PTGS2—coronary artery disease	6.1e-07	6.93e-06	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—APOA1—coronary artery disease	6.07e-07	6.89e-06	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—PTGS2—coronary artery disease	5.98e-07	6.79e-06	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—PTGS2—coronary artery disease	5.96e-07	6.78e-06	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—GGT1—coronary artery disease	5.96e-07	6.77e-06	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—GOT1—coronary artery disease	5.96e-07	6.77e-06	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—CD36—coronary artery disease	5.94e-07	6.75e-06	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—ALB—coronary artery disease	5.91e-07	6.71e-06	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—PPP2CA—coronary artery disease	5.87e-07	6.67e-06	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—PPARG—coronary artery disease	5.86e-07	6.66e-06	CbGpPWpGaD
Tamoxifen—CYP19A1—Metabolism—PIK3CA—coronary artery disease	5.85e-07	6.64e-06	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	5.81e-07	6.6e-06	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—POMC—coronary artery disease	5.78e-07	6.57e-06	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—PPARG—coronary artery disease	5.72e-07	6.5e-06	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—NOS3—coronary artery disease	5.65e-07	6.42e-06	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—POMC—coronary artery disease	5.64e-07	6.41e-06	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—PTGS2—coronary artery disease	5.64e-07	6.4e-06	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—MTHFR—coronary artery disease	5.63e-07	6.4e-06	CbGpPWpGaD
Tamoxifen—CYP1B1—Metabolism—PIK3CA—coronary artery disease	5.63e-07	6.4e-06	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—VEGFA—coronary artery disease	5.6e-07	6.37e-06	CbGpPWpGaD
Tamoxifen—ESR1—Gene Expression—AKT1—coronary artery disease	5.5e-07	6.25e-06	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—PPARG—coronary artery disease	5.39e-07	6.13e-06	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—GSTP1—coronary artery disease	5.35e-07	6.08e-06	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—AGT—coronary artery disease	5.35e-07	6.08e-06	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—PPARG—coronary artery disease	5.34e-07	6.07e-06	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—POMC—coronary artery disease	5.32e-07	6.04e-06	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—PPARGC1A—coronary artery disease	5.3e-07	6.02e-06	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—HMOX1—coronary artery disease	5.28e-07	6e-06	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—POMC—coronary artery disease	5.27e-07	5.99e-06	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—ALB—coronary artery disease	5.27e-07	5.99e-06	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—APOE—coronary artery disease	5.24e-07	5.96e-06	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—CAT—coronary artery disease	5.21e-07	5.92e-06	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—APOA1—coronary artery disease	5.18e-07	5.89e-06	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—PTGS2—coronary artery disease	5.17e-07	5.87e-06	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—ALB—coronary artery disease	5.14e-07	5.84e-06	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—TGFB1—coronary artery disease	5.14e-07	5.84e-06	CbGpPWpGaD
Tamoxifen—ABCG2—Metabolism—PIK3CA—coronary artery disease	5.12e-07	5.82e-06	CbGpPWpGaD
Tamoxifen—CYP3A7—Metabolism—PIK3CA—coronary artery disease	5.08e-07	5.77e-06	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—APOB—coronary artery disease	5.06e-07	5.74e-06	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—MAPK1—coronary artery disease	5.04e-07	5.73e-06	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—NOS3—coronary artery disease	5.04e-07	5.73e-06	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	4.96e-07	5.64e-06	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—NOS3—coronary artery disease	4.92e-07	5.59e-06	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—GSTM1—coronary artery disease	4.92e-07	5.59e-06	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—ALB—coronary artery disease	4.85e-07	5.51e-06	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—LPL—coronary artery disease	4.83e-07	5.48e-06	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—ALB—coronary artery disease	4.81e-07	5.46e-06	CbGpPWpGaD
Tamoxifen—CYP19A1—Metabolism—AKT1—coronary artery disease	4.78e-07	5.43e-06	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—GPX1—coronary artery disease	4.71e-07	5.35e-06	CbGpPWpGaD
Tamoxifen—CYP2A6—Metabolism—PIK3CA—coronary artery disease	4.65e-07	5.29e-06	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—NOS3—coronary artery disease	4.64e-07	5.27e-06	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—PTGS2—coronary artery disease	4.61e-07	5.24e-06	CbGpPWpGaD
Tamoxifen—CYP1B1—Metabolism—AKT1—coronary artery disease	4.6e-07	5.22e-06	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—NOS3—coronary artery disease	4.6e-07	5.22e-06	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—CD36—coronary artery disease	4.59e-07	5.21e-06	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—PPARG—coronary artery disease	4.57e-07	5.19e-06	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—PPP2CA—coronary artery disease	4.53e-07	5.15e-06	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—POMC—coronary artery disease	4.5e-07	5.12e-06	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—PTGS2—coronary artery disease	4.5e-07	5.11e-06	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—PIK3CA—coronary artery disease	4.38e-07	4.97e-06	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—MTHFR—coronary artery disease	4.35e-07	4.94e-06	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—PTGS2—coronary artery disease	4.24e-07	4.82e-06	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—PTGS2—coronary artery disease	4.2e-07	4.78e-06	CbGpPWpGaD
Tamoxifen—ABCG2—Metabolism—AKT1—coronary artery disease	4.18e-07	4.75e-06	CbGpPWpGaD
Tamoxifen—CYP3A7—Metabolism—AKT1—coronary artery disease	4.15e-07	4.71e-06	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—AGT—coronary artery disease	4.13e-07	4.69e-06	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—ALB—coronary artery disease	4.11e-07	4.67e-06	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—APOE—coronary artery disease	4.05e-07	4.6e-06	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—APOA1—coronary artery disease	4e-07	4.54e-06	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—NOS3—coronary artery disease	3.93e-07	4.46e-06	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—IL6—coronary artery disease	3.88e-07	4.4e-06	CbGpPWpGaD
Tamoxifen—CYP2A6—Metabolism—AKT1—coronary artery disease	3.8e-07	4.32e-06	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—PIK3CA—coronary artery disease	3.75e-07	4.27e-06	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—PIK3CA—coronary artery disease	3.68e-07	4.18e-06	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—PIK3CA—coronary artery disease	3.67e-07	4.17e-06	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—PTGS2—coronary artery disease	3.59e-07	4.08e-06	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—AKT1—coronary artery disease	3.58e-07	4.06e-06	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—PPARG—coronary artery disease	3.53e-07	4e-06	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—POMC—coronary artery disease	3.48e-07	3.95e-06	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—PIK3CA—coronary artery disease	3.47e-07	3.94e-06	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—PIK3CA—coronary artery disease	3.18e-07	3.61e-06	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—ALB—coronary artery disease	3.17e-07	3.6e-06	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—AKT1—coronary artery disease	3.07e-07	3.48e-06	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—NOS3—coronary artery disease	3.03e-07	3.44e-06	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—AKT1—coronary artery disease	3e-07	3.41e-06	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—AKT1—coronary artery disease	3e-07	3.41e-06	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—PIK3CA—coronary artery disease	2.84e-07	3.22e-06	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—AKT1—coronary artery disease	2.83e-07	3.22e-06	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—PTGS2—coronary artery disease	2.77e-07	3.15e-06	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—PIK3CA—coronary artery disease	2.77e-07	3.15e-06	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—PIK3CA—coronary artery disease	2.61e-07	2.96e-06	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—AKT1—coronary artery disease	2.6e-07	2.95e-06	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—PIK3CA—coronary artery disease	2.59e-07	2.94e-06	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—AKT1—coronary artery disease	2.32e-07	2.63e-06	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—AKT1—coronary artery disease	2.26e-07	2.57e-06	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—PIK3CA—coronary artery disease	2.21e-07	2.51e-06	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—AKT1—coronary artery disease	2.13e-07	2.42e-06	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—AKT1—coronary artery disease	2.11e-07	2.4e-06	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—AKT1—coronary artery disease	1.81e-07	2.05e-06	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—PIK3CA—coronary artery disease	1.71e-07	1.94e-06	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—AKT1—coronary artery disease	1.39e-07	1.58e-06	CbGpPWpGaD
